Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CDXC

ChromaDex (CDXC)

ChromaDex Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CDXC
DateTimeSourceHeadlineSymbolCompany
03/23/20206:30AMGlobeNewswire Inc.Cellular Health Market Leader Tru Niagen® Launches Online in AustraliaNASDAQ:CDXCChromaDex Corporation
03/19/20209:47AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CDXCChromaDex Corporation
03/12/20204:44PMGlobeNewswire Inc.ChromaDex Corrects Statements Made by an Unaffiliated Third Party Regarding its Product and COVID-19NASDAQ:CDXCChromaDex Corporation
03/10/20204:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CDXCChromaDex Corporation
03/10/20204:03PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:CDXCChromaDex Corporation
03/10/20204:01PMGlobeNewswire Inc.CHROMADEX CORPORATION REPORTS 2019 FINANCIAL RESULTSNASDAQ:CDXCChromaDex Corporation
02/27/20206:30AMGlobeNewswire Inc.New Niagen® Nicotinamide Riboside (NR) Study Deepens Understanding of NAD Decline and Hearing Loss in Animal ModelNASDAQ:CDXCChromaDex Corporation
02/25/20206:30AMGlobeNewswire Inc.ChromaDex to Report Fourth Quarter 2019 Financial Results on Tuesday, March 10, 2020NASDAQ:CDXCChromaDex Corporation
02/14/20204:22PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:CDXCChromaDex Corporation
02/12/20206:30AMGlobeNewswire Inc.ChromaDex Partners with Personalized Nutrition Company, Persona Nutrition, Expanding Global Partnership with Nestlé Health S...NASDAQ:CDXCChromaDex Corporation
02/03/20206:30AMGlobeNewswire Inc.ChromaDex Launches New Line of High Purity Cannabinoid (CBD) Reference Standards Available for Research and Analytical Testin...NASDAQ:CDXCChromaDex Corporation
01/15/20206:30AMGlobeNewswire Inc.ChromaDex Achieves New Regulatory Milestones in the European Union & AustraliaNASDAQ:CDXCChromaDex Corporation
01/10/20205:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CDXCChromaDex Corporation
01/06/20206:30AMGlobeNewswire Inc.First-of-its-Kind Clinical Study Initiated to Investigate Potential Benefits of Nicotinamide Riboside Combined with Exercise ...NASDAQ:CDXCChromaDex Corporation
12/16/20196:30AMGlobeNewswire Inc.ChromaDex Wins Nutritional Outlook’s 2019 “Best of Industry” Ingredient Supplier Award for Niagen®NASDAQ:CDXCChromaDex Corporation
12/11/20196:30AMGlobeNewswire Inc.ChromaDex Launches Tru Niagen® Pro 500, the Largest Serving of Patented Nicotinamide Riboside Available WorldwideNASDAQ:CDXCChromaDex Corporation
12/05/20196:30AMGlobeNewswire Inc.ChromaDex and Matakana Announce Expanded Retail Partnership in Australia & New ZealandNASDAQ:CDXCChromaDex Corporation
12/02/20196:30AMGlobeNewswire Inc.ChromaDex Receives Approval for Nicotinamide Riboside Chloride as an Ingredient for Complementary Medicines from the Australi...NASDAQ:CDXCChromaDex Corporation
11/20/20196:30AMGlobeNewswire Inc.European Commission Votes in Favor on Nicotinamide Riboside Chloride as a Novel FoodNASDAQ:CDXCChromaDex Corporation
11/15/201910:51AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDXCChromaDex Corporation
11/12/20194:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CDXCChromaDex Corporation
11/12/20194:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CDXCChromaDex Corporation
11/12/20194:03PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CDXCChromaDex Corporation
11/12/20194:01PMGlobeNewswire Inc.ChromaDex Corporation Reports Third Quarter 2019 Financial Results   NASDAQ:CDXCChromaDex Corporation
11/04/20196:30AMGlobeNewswire Inc.ChromaDex to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019NASDAQ:CDXCChromaDex Corporation
10/31/20196:30AMGlobeNewswire Inc.Tru Niagen® Wins ‘Most Favourite Brand’ Award Among Watsons Hong Kong Loyalty MembersNASDAQ:CDXCChromaDex Corporation
10/24/201912:26PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CDXCChromaDex Corporation
10/24/201912:24PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CDXCChromaDex Corporation
10/17/20196:30AMGlobeNewswire Inc.New Study Demonstrates a Unique Role of Nicotinamide Riboside Over Other NAD PrecursorsNASDAQ:CDXCChromaDex Corporation
10/11/20196:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CDXCChromaDex Corporation
 Showing the most relevant articles for your search:NASDAQ:CDXC